首页> 外文期刊>The pharmaceutical journal >Asthma mortality in the UK is too high,but pharmacy can help
【24h】

Asthma mortality in the UK is too high,but pharmacy can help

机译:英国的哮喘死亡率太高,但药房可以帮助

获取原文
获取原文并翻译 | 示例
           

摘要

Asthma may be a treatable disease,but it can be a killer.The UK has the fourth worst asthma mortality rate in Europe1.Around 5.4 million people(1.1 million children and 4.3 million adults)receive treatment for asthma in the UK,but 1,434 people died from an asthma attack in the UK in 2015-up by more than 20% since 20112.The National Review of Asthma Deaths(NRAD),’Why asthma still kills’looked into the circumstances surrounding 195 deaths from asthma recorded between 1 February 2012 and 30 January 2013.It was published in August 2015 and suggests that more than 60% of the asthma deatirs it reported could have been prevented.The results of the review showed some uncomfortable findings3: 10% of these patients died within 28 days of discharge from hospital after being treated for asthma;Only 23% of these patients had been provided with personal asthma action plans(PAAPs),which are acknowledged to improve asthma care;43% of these patients had not received an asthma review in the last year of their life;50% of these patients did not have triggers or exacerbating factors documented.
机译:哮喘可能是一种可治疗的疾病,但它可以是杀手。英国拥有欧洲的第四个最严重的哮喘死亡率1. around 540万人(110万儿童和430万人)接受英国哮喘的治疗,但1,434人自20112年以来,从英国的哮喘发作死于20112年以上的20%以上。国家哮喘死亡(NRAD)的国家评论'为什么哮喘仍然杀人在2012年2月1日之间记录的哮喘患者的195次死亡的情况和2013年1月30日。它于2015年8月出版,并提出了超过60%的哮喘Deatirs,它据报道,可以预防。该审查结果显示出一些不舒服的发现3:10%的患者在出院后28天内死亡从医院治疗哮喘后。只有23%的患者提供了个人哮喘行动计划(皮带),该计划被承认改善哮喘护理; 43%的患者在去年没有接受过哮喘审查他们的生活; 50%的这些患者没有记录或加剧因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号